Cargando…
Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population
INTRODUCTION: The systemic viral disease caused by the SARS-CoV-2 called coronavirus disease 2019 (COVID-19) continues to be a public health problem worldwide. OBJECTIVE: This study is aimed to evaluate the association and predictive value of indices of systemic inflammation with severity and non-su...
Autores principales: | Gutiérrez-Pérez, Ilse Adriana, Buendía-Roldán, Ivette, Pérez-Rubio, Gloria, Chávez-Galán, Leslie, Hernández-Zenteno, Rafael de Jesus, Aguilar-Duran, Hiram, Fricke-Galindo, Ingrid, Zaragoza-García, Oscar, Falfán-Valencia, Ramcés, Guzmán-Guzmán, Iris Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633849/ https://www.ncbi.nlm.nih.gov/pubmed/36341268 http://dx.doi.org/10.3389/fmed.2022.1000147 |
Ejemplares similares
-
The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19
por: Valencia-Pérez Rea, Daniela, et al.
Publicado: (2023) -
Editorial: Translational research in severe COVID-19 and long-term symptoms post-COVID-19
por: Vicens-Zygmunt, Vanesa, et al.
Publicado: (2023) -
IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19
por: Fricke-Galindo, Ingrid, et al.
Publicado: (2022) -
Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation
por: Chavez-Galan, Leslie, et al.
Publicado: (2022) -
COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B
por: García-Carmona, Salvador, et al.
Publicado: (2022)